What's new

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 10, Status: Authorised

Mar 27, 2025 - 12:04
 0
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Trump imposes 25% tariff on all auto imports to the US

Next Article

Metals Innovation Initiative taps recycling industry veteran to lead board

Related Posts

Human medicines European public assessment report (EPAR): Aripiprazole Accord, aripiprazole, Date of authorisation: 15/11/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): Efient, prasugrel, Date of authorisation: 24/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Orphan designation: xevinapant Treatment of ovarian cancer, 11/11/2015 Withdrawn

Orphan designation: xevinapant Treatment of ovarian can...

Feb 20, 2025  0